BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

Nishat duo to buy back 285m shares

PPL rejects reports of Artificial Island

TPL Corp swings to Rs1bn profit on strong revenue surge

Name	Price/Vol	%Chg/NChg
KSE100	163,018.66 138.30M	0.05% 81.72
ALLSHR	98,973.80 403.59M	0.17% 164.66
KSE30	49,460.79 51.40M	0.03% 14.97
KMI30	233,011.03 39.62M	0.13% 295.18
KMIALLSHR	64,476.20 200.81M	0.14% 88.53
BKTi	44,076.19 19.45M	0.29% 129.30
OGTi	32,306.98 7.87M	0.17% 56.15

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	84,190.00	88,150.00 81,485.00	-2250.00 -2.60%
BRENT CRUDE	62.54	63.02 62.20	-0.84 -1.33%
RICHARDS BAY COAL MONTHLY	85.00	0.00 0.00	0.25 0.30%
ROTTERDAM COAL MONTHLY	96.25	0.00 0.00	0.15 0.16%
USD RBD PALM OLEIN	1,082.50	1,082.50 1,082.50	0.00 0.00%
CRUDE OIL - WTI	58.08	58.80 57.75	-0.92 -1.56%
SUGAR #11 WORLD	14.60	14.74 14.59	-0.06 -0.41%